Nanci Valeis

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial.

L. Piegas, A. Parkhomenko, H. White, 2019, Journal of the American College of Cardiology.

Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.

R. Lopes, J. Alexander, A. Cavalcanti, 2020, The New England journal of medicine.

Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial

L. Piegas, A. Parkhomenko, H. White, 2018, JAMA cardiology.

Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST‐elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial

L. Piegas, A. Parkhomenko, H. White, 2018, American heart journal.

IMPACTO-MR: a Brazilian nationwide platform study to assess infections and multidrug resistance in intensive care units

Daniel de Oliveira, F. Machado, F. Dal-Pizzol, 2022, Revista Brasileira de terapia intensiva.

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial.

L. Piegas, A. Parkhomenko, H. White, 2019, Journal of the American College of Cardiology.

High flow nasal catheter therapy versus non-invasive positive pressure ventilation in acute respiratory failure (RENOVATE trial): protocol and statistical analysis plan

L. Brochard, A. Cavalcanti, I. Maia, 2022, Critical Care and Resuscitation.

Halofuginone for non-hospitalized adult patients with COVID-19 a multicenter, randomized placebo-controlled phase 2 trial. The HALOS trial

J. Esko, S. Tsimikas, B. Tomazini, 2024, PloS one.